Boston Scientific Corporation (BIT:1BSX)
87.40
+1.00 (1.16%)
At close: Oct 31, 2025
Boston Scientific Revenue
Boston Scientific had revenue of $5.07B USD in the quarter ending September 30, 2025, with 20.34% growth. This brings the company's revenue in the last twelve months to $19.35B, up 21.61% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.
Revenue (ttm)
$19.35B
Revenue Growth
+21.61%
P/S Ratio
7.85
Revenue / Employee
$365.08K
Employees
53,000
Market Cap
129.39B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
| Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
| Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
| Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
| Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Stellantis | 146.12B |
| Eni S.p.A. | 86.56B |
| Enel SpA | 77.79B |
| Assicurazioni Generali | 56.79B |
| Intesa Sanpaolo | 25.38B |
| UniCredit | 24.85B |
| Prysmian | 19.85B |
| Leonardo S.p.a. | 18.70B |